Next Article in Journal
Suppressive Role of Lactoferrin in Overweight-Related Female Fertility Problems
Next Article in Special Issue
Influence of Gluten-Free Diet on Gut Microbiota Composition in Patients with Coeliac Disease: A Systematic Review
Previous Article in Journal
Effects of the Mediterranean Diet on Morbidity from Inflammatory and Recurrent Diseases with Special Reference to Childhood Asthma
Previous Article in Special Issue
The Efficacy of Short-Term Weight Loss Programs and Consumption of Natural Probiotic Bryndza Cheese on Gut Microbiota Composition in Women
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 5
10.3390/nu14050937
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Whole Brown Bean and Its Isolated Fiber Fraction on Plasma Lipid Profile, Atherosclerosis, Gut Microbiota, and Microbiota-Dependent Metabolites in Apoe−/− Mice

by
Jiyun Liu
1,*,
Mohammed E. Hefni
1,2,
Cornelia M. Witthöft
1,
Maria Bergström
1,
Stephen Burleigh
3,
Margareta Nyman
3 and
Frida Hållenius
3
1
Department of Chemistry and Biomedical Sciences, Faculty of Health and Life Sciences, Linnaeus University, 39231 Kalmar, Sweden
2
Food Industries Department, Faculty of Agriculture, Mansoura University, Mansoura 35516, Egypt
3
Department of Food Technology, Engineering and Nutrition, Lund University, 22100 Lund, Sweden
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(5), 937; https://doi.org/10.3390/nu14050937
Submission received: 20 January 2022 / Revised: 10 February 2022 / Accepted: 18 February 2022 / Published: 22 February 2022
(This article belongs to the Special Issue Effect of a Nutritional Intervention on the Intestinal Microbiota)
Browse Figures
Versions Notes

Abstract

:
The health benefits of bean consumption are widely recognized and are largely attributed to the dietary fiber content. This study investigated and compared the effects of whole brown beans and an isolated bean dietary fiber fraction on the plasma lipid profile, atherosclerotic plaque amount, gut microbiota, and microbiota-dependent metabolites (cecal short-chain fatty acids (SCFAs) and plasma methylamines) in Apoe−/− mice fed high fat diets for 10.5 weeks. The results showed that both whole bean and the isolated fiber fraction had a tendency to lower atherosclerotic plaque amount, but not plasma lipid concentration. The whole bean diet led to a significantly higher diversity of gut microbiota compared with the high fat diet. Both bean diets resulted in a lower Firmicutes/Bacteroidetes ratio, higher relative abundance of unclassified S24-7, Prevotella, Bifidobacterium, and unclassified Clostridiales, and lower abundance of Lactobacillus. Both bean diets resulted in higher formation of all cecal SCFAs (higher proportion of propionic acid and lower proportion of acetic acid) and higher plasma trimethylamine N-oxide concentrations compared with the high fat diet. Whole beans and the isolated fiber fraction exerted similar positive effects on atherosclerotic plaque amount, gut microbiota, and cecal SCFAs in Apoe−/− mice compared with the control diets.

Graphical Abstract

1. Introduction

Pulse foods are attracting attention due to their health benefits, especially in the prevention of metabolic and cardiovascular diseases [1,2,3]. For example, a cross-sectional study of Iranian adults showed that pulse consumption decreased the risk of metabolic diseases [1], and an epidemiological follow-up study indicated that pulse intake is associated with a decreased risk of heart disease [2]. A meta-analysis of randomized controlled trials showed that a diet rich in pulses can decrease total and low-density lipoprotein (LDL) cholesterol in blood [3].
The beneficial effects of pulses are often associated with their high content of dietary fiber (non-starch polysaccharides) and other indigestible carbohydrates (resistant starch and oligosaccharides) and polyphenols [4,5]. Among all of the pulse types, common beans (Phaseolus vulgaris L.) contain the highest level of fermentable fiber and have the highest in vitro fermentability [6].
Gut microbiota also play an important role in maintaining metabolic health. Dysbiosis, characterized by a decrease in microbial diversity and an increase in proinflammatory species, has been linked with obesity, diabetes, and atherosclerotic cardiovascular disease [7,8]. Lower abundance of Bacteroidetes and proportionally higher abundance of Firmicutes has been found in obese subjects compared with lean subjects in both human and mouse studies [9,10]. Diet plays an important role in shaping the gut microbiota [11,12]. Positive effects of dietary pulses on gut microbiota have been reported in both in vitro and in vivo studies [13,14].
The effects of gut microbiota are often mediated by their metabolites. Short-chain fatty acids (SCFA) have an important role in health and diseases, as they are the main metabolites produced by gut microbiota from indigestible carbohydrate [15]. The SCFA profile depends on several factors, such as the physicochemical properties and monomeric composition of the fiber and the composition of the gut microbiota [16]. SCFAs show activity in maintaining colonic health, integrity, and immunity, with butyric acid being the most potent member, followed by propionic and acetic acid [15]. Most of the known butyric acid-producing bacteria belong to the phylum Firmicutes [17].
Trimethylamine N-oxide (TMAO) is another important microbiota-dependent metabolite. It can be produced from trimethylamine (TMA) in the liver, while TMA is generated by gut microbiota from precursors such as choline and carnitine [18]. Various bacterial phyla, including Firmicutes, Proteobacteria, and Actinobacteria, are capable of producing TMAO [19]. The increased concentration of TMAO in plasma resulting from gut microbiota dysbiosis is suggested to be a risk factor for atherosclerosis [20].
Brown bean (Phaseolus vulgaris L.) is one of the most important types of pulses consumed in Sweden. A previous study showed that an evening meal of brown beans can beneficially alter blood glucose, insulin, and appetite regulatory hormones, and promote plasma SCFA concentrations in human subjects [21]. However, the effects of brown beans on plasma lipid profile, regulation of gut microbiota, and prevention of atherosclerosis have not been fully studied. The role of dietary fiber of beans has also not been fully investigated. The aim of this study was therefore to evaluate and compare the effects of whole brown beans and the isolated dietary fiber fraction on lipid profile, atherosclerotic plaque amount, gut microbiota, and microbiota-dependent metabolites in Apoe−/− mice fed a high fat (HF) diet.

2. Materials and Methods

2.1. Preparation of Whole Bean and Fiber Fraction

Brown bean (Phaseolus vulgaris L. var. Katja) obtained from Kalmar-Ölands Trädgårdsprodukter (KÖTP, Färjestaden, Sweden) was used for the preparation of lyophilized boiled whole brown bean (Wbean) and a brown bean fiber (Bfiber) fraction to be incorporated into experimental diets. The beans were prepared following the cooking instructions provided by KÖTP. In brief, after overnight soaking (14 h) and boiling in water for 60 min, the cooked brown beans were collected and lyophilized (BenchTop Pro, SP VirTis, Gardiner, NY, USA), milled (Cyclotec 1093, Foss Tecator, Hillerød, Denmark), and stored at −20 °C.
The preparation of the Bfiber fraction from lyophilized boiled Wbean followed the protocol provided by Megazyme Ltd. (Bray, Ireland) (based on AOAC Method 985.29), with some modifications. In brief, the bean lyophilizate was mixed with distilled water to a final volume of 100 g/L. Thermostable α-amylase was added and the solution was incubated in a boiling water bath for 45 min. After cooling, protease was added to hydrolyze the proteins at 60 °C [22] for 45 min. Then, 0.5 M HCl was used to adjust the pH of the suspension to 4.8 and amyloglucosidase was added, followed by incubation at 60 °C [23] for another 45 min. Four times volume of ethanol (95%) was added to the dispersion to precipitate the fiber. The Bfiber fraction was filtered and then washed with 80% ethanol. The residue was lyophilized to obtain the bean fiber fraction.
The Wbean and the Bfiber fraction were shipped to Research Diets (New Brunswick, NJ, USA) for preparation of the experimental diets. There were two control diets (a high fat (HF) and a low fat (LF) diet) and two bean (Wbean and Bfiber) high fat diets. Each diet included 60 g/kg of cellulose or dietary fiber from beans. Corn starch was used to adjust dry matter content. A detailed description of the diets is given in Table S1 in the Supplementary Material.

2.2. Design of Animal Study

Six-week-old female Apoe−/− mice obtained from Taconic Biosciences Inc. (Silkeborg, Denmark) were randomly divided into four groups, with 10 mice per group. They were housed five per cage in a controlled environment (12 h day/night cycle, 22 °C) with feed and water ad libitum. At the beginning of the study, the mice were allowed to adapt to the environment for one week with regular chow pellets. The diet was then changed to one of the four experimental diets (HF, LF, Wbean, and Bfiber) for each group (Table S1 in the Supplementary Material). During the 10.5-week feeding period, the weight of the mice and the diet consumption in each cage were recorded weekly. One mouse in the LF group and one in the Wbean group had skin irritation during the feeding period (related to the poor physical constitution of individual mice, rather than the diets), and were excluded from the study. At the end of the feeding period, the mice were anesthetized in chambers saturated with isoflurane and then sacrificed by cardiac puncture. Blood (1 mL) was collected and immediately centrifuged to separate the plasma. The liver and fat pads were weighed. The heart, including the aortic arch, was harvested. The cecal tissue and contents were weighed, collected, and stored at −80 °C for analysis of SCFAs and gut microbiota.
The animal study was approved by the Malmö–Lund Ethics Committee on Animal Experiments (ethical approval number: 9874-20).

2.3. Analytical Methods

2.3.1. Characterization of Whole Bean and the Fiber Fraction

Dietary fiber. The content of dietary fiber in Wbean and the Bfiber fraction was measured using a commercially available total dietary fiber kit (Megazyme, Ltd., Bray, Ireland). The neutral sugar composition of the fiber was determined using GC–FID and the content of uronic acids was determined colorimetrically [24].
Protein, fat, ash, and carbohydrate. The content of the total protein was determined according to AOAC method 992.15, fat content according to AOAC method 989.05, moisture content according to AOAC method 925.10, and ash content according to AOAC method 923.03. Carbohydrate content was determined by difference (i.e., 100%—%(Fat + Protein + Fiber + Moisture + Ash)).

2.3.2. Analysis of Biological Samples

Lipid profiles in plasma. Plasma levels of triglycerides (TG), total cholesterol, high-density lipoprotein (HDL) cholesterol, and LDL cholesterol were determined using colorimetric kits (Thermo Fisher Scientific Inc., Waltham, MA, USA).
Atherosclerotic plaques. Mice hearts (2–5 mice per group) were embedded in OCT cryomount medium and sent to Histocenter (Gothenburg, Sweden) for the preparation of slides. The hearts were cut into 10 μm sections for histological analysis of atherosclerotic plaques. After staining with Oil Red O (ORO) (Histolab, Gothenburg, Sweden) and hematoxylin (MAYERS HTX, Histolab, Gothenburg, Sweden), representative images of aortic sections were obtained using a camera–microscope system (Nikon Eclipse E400) with imaging software (NIS-Elements 4.13) (both Nikon Instruments Inc., Tokyo, Japan). The atherosclerotic plaque amount (ratio of plaque area to total vessel area, %) was quantified using BioPixQ 2.0 software (BIOPIX software, Gothenburg, Sweden).
Creatinine and methylamines in plasma. The creatinine and methylamines in plasma were measured as previously described with some modifications [25]. In brief, the plasma samples (25 μL) were mixed with internal standard (50 μmol/L, 10 μL, containing betaine-d11, trimethylamine-d9, trimethylamine-N-oxide-d9, creatinine-d3, L-carnitine-d3, acetyl-DL-carnitine-d3), iodoacetonitrile (5 μL), NH4OH (2 μL), and CH3CN: CH3OH (90:10, v/v, 458 μL) and vortexed for 5 min, centrifuged (13,000× g, 5 min), and filtered through a 0.45 μm Millipore filter (Agilent, St. Clara, CA, USA). The supernatant was collected for LC–MS analysis (Agilent 1200, Agilent Technologies, Santa Clara, CA, USA). Methylamines and creatinine were separated using a neutral HILIC column (ACE, 150 mm × 4.6 mm; particle size 3 μm). The mobile phase consisted of 25 mM ammonium formate in water: CH3CN (30:70, v/v). The flow rate was set to 0.6 mL/min and the injection volume to 10 μL. Quantification was based on external calibration and internal standards.
SCFAs in cecum. The content and profile of SCFAs (acetic, propionic, butyric, isobutyric, valeric, isovaleric, caproic, and heptanoic acids) in the cecum were analyzed using a GC–FID method [26] with 2-ethylbutyric acid as the internal standard. In brief, hydrochloric acid (0.25 M) was mixed with the samples and vortexed for 5 min. The suspension was then centrifuged (8000× g, 20 min), and the supernatant was collected and injected into an Agilent DB-FFAP column (30 m × 0.53 mm, 0.50 μm film thickness) for GC analysis (Agilent GC7890B). The parameters were set as: splitless mode, flow of carrier gas 4.4 mL/min, and temperature of injection port 250 °C. The temperature gradient was as follows: 0–2 min, 80 °C; 2–14.5 min, 80–180 °C; 14.5–15.5 min, 180 °C; 15.5–16.5 min, 180–200 °C; 16.5–21.5 min, 200 °C.

2.4. 16S rRNA Gene-Based Gut Microbial Analysis

Bacterial genomic 16S rRNA gene sequencing was carried out by Clinical Microbiomics Laboratory (Copenhagen, Denmark). In brief, bacterial DNA was extracted from cecal content by bead-beating, using the QIAamp DNA Stool Mini kit (Qiagen, Limburg, Germany). The 27F forward (AGAGTTTGATCCTGGCTCAG) and 534R reverse (ATTACCGCGGCTGCTGG) primers containing adapter sequences (Illumina, San Diego, CA, USA) with unique dual indices to tag each PCR product were used to amplify genes by PCR [27]. Paired-end sequencing with a read length of 2 × 300 bp was performed on a Miseq instrument (Illumina), using a Miseq Reagent kit v3 (Illumina). The 16S rRNA gene sequences were analyzed using Quantitative Insights into Microbial Ecology (QIIME, version 1) for high-throughput community data. After quality filtering, a total of 1,181,458 sequences of operational taxonomic units (OTUs) were generated. An average count of 31,931 sequences was assigned to each sample (range 18,108 to 56,608 sequences/sample). The sequences were normalized by rarefaction (depth of 18,000), grouped into OTUs at a minimum of 97% similarity using the closed reference method based on the Greengenes database (v. 13.8), and filtered by the removal of singletons and low abundance OTUs (minimum count fraction set at 0.001).

2.5. Statistical Analyses

GraphPad Prism 9.2.0 (GraphPad, La Jolla, CA, USA) and Excel (Microsoft, Redmond, WA, USA) were used for univariate analysis. Unless otherwise stated, the differences between groups were assessed by Student’s t-test or by one-way ANOVA, followed by Tukey’s multiple comparison test. Welch’s ANOVA test followed by Dunnett’s T3 multiple comparison test was used when the requirement of equal standard deviations (SDs) was not fulfilled. For the non-parametric taxonomy data, Wilcox test followed by Dunn’s test for multiple comparisons was applied. The significance was set to p < 0.05, while p < 0.1 was considered to indicate a tendency.
For multivariate analysis, a QIIME-based permanova (using the pseudo-F statistical test and 999 permutations) was used to test for overall differences in the microbiomes between groups. Spearman’s correlation analysis was performed using Prism 9.2.0 (GraphPad, La Jolla, CA, USA) with p < 0.05 to explore the correlations between TMAO, gut microbiota, and atherosclerotic plaque amount. Principal component analysis (PCA) was performed using MATLAB (MathWorks, Natick, MA, USA) to explore the correlations of different diets to the biomarkers and gut microbiota.

3. Results

3.1. Characterization of Whole Bean and the Fiber Fraction

The total content of dietary fiber in whole brown beans and in the fiber fraction isolated from brown beans was 27 and 56 g/100 g dry weight (dwt), respectively. The fiber consisted mainly of arabinose (36%), followed by glucose (29%) and uronic acids (13%). Considerable amounts of xylose (10%), galactose (7%) and fucose (3%) were also found (Figure S1 in the Supplementary Material). Polyphenolic compounds (513 μg/g) were detected only in the whole bean samples (Table S2 in the Supplementary Material).

3.2. Diet Intake, Weight Gain, and Organ Weight Ratios

Mice in the LF group showed 19% lower cecum-to-body weight ratio compared with mice in the HF group (p < 0.05). No significant differences in body weight gain or other organ weight ratios were observed between the controls.
Mice fed the two bean diets had significantly higher diet intake and body weight gain compared with mice in the HF group (p < 0.0001). The Bfiber group had a higher cecum-to-body weight ratio compared with the HF group (p < 0.05) (Figure S2 in the Supplementary Material).

3.3. Plasma Lipid Profiles and Atherosclerotic Plaque

The LF group had lower total and LDL cholesterol levels (p < 0.0001), and lower atherosclerotic plaque amount (p < 0.001) compared with the HF group.
No significant differences in the plasma lipid profile were observed between the HF and two bean groups. Inclusion of Wbean or Bfiber in the HF diet resulted in a tendency (p = 0.1 and 0.07, respectively) for lower atherosclerotic plaque amount compared with the HF diet (Figure 1).

3.4. Cecal SCFAs

The LF diet resulted in 8% lower proportion of acetic acid (p < 0.01), and 30% higher pool and 25% higher proportion of butyric acid in cecum, compared with the HF diet (p < 0.05).
Mice fed the Wbean or Bfiber diet had higher cecal pools of total and individual SCFAs (p < 0.05) than mice fed the HF diet. Both bean diets also led to lower proportions of acetic acid and higher proportions of propionic acid compared with the HF diet. Mice fed the Wbean diet showed a tendency (p = 0.1) for a higher proportion of butyric acid compared with mice fed the HF diet. Besides, mice fed the Bfiber diet had a lower proportion (p < 0.05) of minor acids (including isobutyric, valeric, isovaleric, caproic, and heptanoic acids) compared with mice fed the HF diet. There were no significant differences between the two bean groups (Figure 2 and Figure S3 in the Supplementary Material).

3.5. Plasma Methylamines

The LF diet led to higher plasma concentrations of TMAO (p < 0.05) and L-carnitine (p < 0.01), and lower concentrations of creatinine (p < 0.05), compared with the HF diet.
Mice fed the Wbean or Bfiber diets had around twice the plasma TMAO concentrations (p < 0.05) seen in mice fed the HF diet. The Bfiber diet resulted in lower plasma creatinine concentrations (p < 0.05) compared with the HF diet, while the Wbean diet gave a lowering tendency (p = 0.09). The plasma choline concentration was higher in the Wbean group than the Bfiber group (p < 0.05) (Figure 3).

3.6. Diversity of Gut Microbiota

Alpha diversity was measured using Chao 1 estimator from rarefaction curves (Figure 4A) and Shannon diversity index (Figure 4B). The rarefaction curves at a range of sampling depths suggested that 31,931 sequences per sample was sufficient. The Wbean group had higher alpha diversity compared with the HF control, according to both the Chao 1 estimator (p < 0.05) and Shannon diversity index (p < 0.05) (Figure 4A,B).
Beta diversity was illustrated by principal coordinates analysis (PCoA) plots of unweighted and weighted UniFrac matrices (Figure 4C,D). Clear separation of cecal microbiota between the mice fed the control diets and the mice fed the bean intervention diets was observed. Moreover, the distances between the control and bean intervention groups were larger in the unweighted UniFrac matrix than in the weighted matrix, suggesting that the groups shared more similarity in the taxa with high relative abundance than those with low abundance.

3.7. Relative Abundance of Gut Microbiota

Significant differences were observed in the composition of gut microbiota between the five treatments based on a QIIME permanova (p < 0.01). These differences were also visually apparent at the phylum level (Figure 5A) and genus level (Figure 6A), and in the PCA biplots (Figure S4 in the Supplementary Material).
The LF diet led to lower relative abundance of Proteobacteria compared with the HF diet (p < 0.001). Both bean groups had higher abundances of Actinobacteria and Bacteroidetes compared with the HF group (p < 0.05). The Bfiber diet resulted in a tendency for lower abundance of Proteobacteria (p = 0.06) compared with the HF diet. Furthermore, the Firmicutes/Bacteroidetes (F/B) ratio was lower in the Wbean (p < 0.01) and Bfiber (p < 0.05) groups than in the HF group (Figure 5).
At the genus level, unclassified Clostridiales (31%) and unclassified S24-7 (24%) were the predominant species in mice fed the bean diets, while Akkermansia (12–17%) and unclassified Clostridiales (12–15%) constituted the majority in mice fed the control diets (Figure 6A). Significant differences (p < 0.05) or tendencies (p < 0.1) for differences in nine genera, i.e., unclassified S24-7, Dehalobacterium, Ruminococcus, Lactobacillus, Bifidobacterium, Prevotella, unclassified Clostridiales, Oscillospira, and Bilophila, were observed between groups (Figure 6B).

3.8. Overall Effects of Diets on Biomarkers and Gut Microbiota

The PCA biplots of the data on organ and body weight, cecal SCFAs, plasma lipids, methylamines, and gut microbiota (Figure S4 in the Supplementary Material) in the mice revealed clear differences between the bean diets and the two control groups. In both biplots, the Wbean or Bfiber groups tended to cluster together, showing similar effects of the two bean diets on biomarkers and gut microbiota. In terms of physiological parameters, the two bean intervention groups were positively correlated with parameters such as cecum weight and the amount of acetic, propionic, and total SCFAs. In terms of gut microbiota, the two bean groups were positively associated with Clostridiales, Ruminococcus, Prevotella, Roseburia, Ruminococcaceae, and unclassified S24-7.

3.9. Correlation between TMAO, Atherosclerotic Plaque, and Gut Microbiota

Plasma TMAO concentration was not found to be correlated with atherosclerotic plaque amount (data not shown), but it was correlated with the bacterial taxa Mucispirillum, SMB53, Peptococcaceae, Anaerotruncus, Oscillospira, Sutterella, and Bilophila. Atherosclerotic plaque amount was correlated to Streptococcus and Ruminococcaceae (p < 0.05).

4. Discussion

‘Dietary fiber’ in this study refers to non-starch polysaccharides, excluding oligosaccharides and resistant starch. Beans are a good source of dietary fiber, and also contain a large amount of protein (19%) (Table S2) and some other indigestible carbohydrates (i.e., resistant starch and oligosaccharides) (up to 10 g/100 g dwt in total [21,28,29]). We evaluated and compared the in vivo effects of whole brown bean and its fiber fraction on the plasma lipid profiles, atherosclerotic plaque amount, gut microbiota, and microbiota-dependent metabolites (cecal SCFAs and plasma methylamines) in Apoe−/− mice. Both the Wbean and Bfiber diets showed a tendency for lower atherosclerotic plaque amount compared with the HF diet, although neither diet resulted in lower body weight or lower plasma lipid concentration. The Wbean diet led to higher alpha diversity of gut microbiota. Both bean diets exhibited similar effects in the modulation of all parameters investigated.

4.1. Effects of Bean Diets on Gut Microbiota

Low diversity of gut microbiota often implies gut dysbiosis and is associated with an unhealthy status of the host [30]. Alpha diversity shows the richness and evenness of microbial species in a sample, while beta diversity shows the variation in microbial communities between samples [31]. We found that the Wbean diet resulted in a higher alpha diversity of gut microbiota compared with the HF diet, while the Bfiber diet did not. Thus, the increase in alpha diversity caused by the Wbean diet may be attributable to components other than the non-starch polysaccharides in cooked beans, such as polyphenols or oligosaccharides. Similarly, diet supplementation with navy bean and black bean has been found to enhance the alpha diversity of gut microbiota in C57BL/6 mice [4]. A kidney bean hull diet was also reported to promote the alpha diversity in rats [32]. There was a clear clustering of the Wbean and Bfiber groups in the unweighted UniFrac PCoA plot (Figure 4C) and the PCA biplot of gut microbiota (Figure S4B in the Supplementary Material), implying that the dietary fiber in brown beans played the main role in the modulation of gut microbiota.
Both bean diets led to higher abundance of Firmicutes and a concurrent decrease in F/B ratio compared with the HF diet (Figure 5). A similar effect has been reported for another common bean, white kidney bean, in C57BL/6 mice [33]. A higher F/B ratio has been found in obese mice and humans compared with their lean counterparts [9,10], but in the present study, we did not observe lower fat accumulation in the bean groups compared with the HF group (Figure S2 in the Supplementary Material). This discrepancy may be due to the use of Apoe−/− mice with a genetic defect in lipid metabolism. Another interesting observation was that there was no significant difference between the HF and two bean groups in relative abundance of the genus Akkermansia, which has been suggested to play an important role in alleviating metabolic disorders and atherosclerosis [34,35]. Enhanced abundance of Akkermansia has previously been reported in the gut microbiota of mice fed white kidney beans [33]. The discrepancy between studies might be explained by proliferation of the phylum Bacteroidetes in mice fed the brown bean diets. It is also worth noting that high abundance of Akkermansia (17%) was found in mice fed the HF diet, as reported previously by Jakobsdottir et al. [36]. Furthermore, we found that both bean groups had a higher abundance of unclassified S24-7, Prevotella, Bifidobacterium, and unclassified Clostridiales, which was in line with findings that supplementation with navy and black beans can stimulate the growth of fiber-fermenting bacteria, including Prevotella, S24-7, and Ruminococcus, in C57BL/6 mice [4]. Both bean diets reversed the decline in Bifidobacterium, a well-acknowledged beneficial microbe, induced by the HF diet (Figure 6B). Similarly, diet supplementation with whole kidney bean has been found to increase the relative abundance of Bifidobacterium in rats [32]. The increase is probably due to ability of Bifidobacterium to digest dietary fiber and other complex carbohydrates [37]. Furthermore, the HF diet led to an increase in Lactobacillus compared with the LF diet (Figure 6B). Although Lactobacillus is usually considered beneficial, some studies suggest that a high fat diet could promote the growth of some specific species of “bad” Lactobacillus associated with obesity [38,39]. Our data indicated that the brown bean interventions could reverse the increased abundance of Lactobacillus driven by the HF diet.

4.2. Effects of Bean Diets on Microbiota-Dependent Metabolites

Higher pools of both total and individual SCFAs in the two bean groups were observed compared with the HF group (Figure 2). This was expected, because the brown bean diets were rich in fermentable carbohydrates compared with the control diets containing cellulose, which is highly resistant to microbial fermentation. Brown bean fiber is mainly composed of arabinose, glucose, uronic acids, and xylose (Figure S1 in the Supplementary Material), which is in line with the previous reports on the predominant neutral sugars of bean fibers [29,40]. The result also implies that cellulose and arabinoxylans were the main constituents. Although knowledge is still limited regarding the bacteria that use arabinoxylans, in an in vitro human intestinal bacterial culture study, the high formation of propionic acid was associated with arabinoxylans [41]. This could be the reason for the high cecal pools of propionic acid in mice fed brown beans (Figure 2). With regard to butyric acid, which is of special interest due to the potent effects in maintaining gut health and intestinal barrier function [42,43], the Wbean diet resulted in higher cecal pool in the mice and showed a tendency (p = 0.1) to increase the proportion of butyric acid compared with the HF diet (Figure 2 and Figure S3 in the Supplementary Material). That might be attributable to the presence of resistant starch and oligosaccharides in the Wbean fraction. Unfortunately, most of the resistant starch and oligosaccharides were lost during the preparation of the fiber fraction [44]. According to the literature data, the content of oligosaccharides and resistant starch in cooked brown bean is 3.2% and 7.6% dwt, respectively [21]. It has been reported that resistant starch and oligosaccharides can increase butyric acid formation in human subjects [45,46,47]. Besides, both bean diets resulted in higher cecal pools of minor acids compared with the HF diet (Figure 2). Minor acids, including branched SCFAs, are associated with fermentation of the indigestible proteins in beans [48].
Plasma TMAO concentrations were higher in the two bean groups than in the HF group (Figure 3). This is an interesting finding, because a high plasma concentration of TMAO is often associated with a risk of atherosclerosis [49]. However, the two bean groups with higher plasma concentrations showed a tendency (p = 0.1 and 0.07) to decrease the atherosclerotic plaque amount. This might be due to the use of Apoe−/− mice, because in several other studies, Apoe−/− mice with higher plasma TMAO concentrations have been found not to develop higher atherosclerotic plaque amount [50,51,52]. It is also worth mentioning that we used female mice, which are reported to have high expression levels of TMA-converting enzymes, resulting in higher basic plasma TMAO concentrations [53]. Furthermore, we observed significant differences in plasma choline between the two bean groups. The differences in plasma methylamines might also be partly attributable to higher dietary intake of feed in the bean groups compared with the control groups. Apart from choline bitartrate (0.25%), which was added to all diets, all but the LF diet contained lard, with 50 mg/100 g choline [54], and pulses contain up to 119 mg/100 g fresh weight of both choline and betaine [55]. Besides, mammals can endogenously synthesize methylamines [56]. Notably, compared with the HF diet, the Bfiber diet resulted in lower plasma creatinine concentrations and the Wbean diet showed a lowering tendency (Figure 3). As high plasma creatinine concentration is considered a predictor of renal disease [57], the results hint at potential protective effects of the bean fiber fraction against kidney disease.
The differences in gut microbiota between the groups could also have resulted from differences in plasma concentrations of methylamines, since gut microbiota are responsible for converting the precursors to TMA. However, little is known about the bacteria that convert specific precursors. The bacterial taxa correlated to TMAO production identified in the present study belong to Deferribacteres, Firmicutes, and Proteobacteria, which is in line with previous findings [19,58]. Our data may confirm a relationship between microbiota and TMAO formation in the Apoe−/− mouse model.

4.3. Effects of Bean Diets on Plasma Lipid Profile and Atherosclerosis Plaque Amount

Neither of the bean diets affected plasma lipid profile compared with the HF diet (Figure 1). This was unexpected, since many animal studies suggest a hypolipidemic effect of bean foods [32,59,60,61]. Diet supplementation with dietary fiber from white kidney bean was reported to reduce total cholesterol in the serum of diabetic rats [59]. Yeap et al. [60] found that feeding diets containing fermented mung beans to hypercholesterolemic mice significantly reduced their serum levels of triglycerides, cholesterol, and LDL cholesterol. Similar cholesterol-lowering effects of pinto beans have been observed using a hamster model [61]. We observed that mice fed the bean diets had higher diet consumption and body weight gain (Figure S2 in the Supplementary Material), which was also inconsistent with previous findings of the weight-lowering effects of another common bean (white kidney bean) in obese mice [33]. The discrepancy between studies in the effects of the two bean types on body weight might be attributable to differences in the bean species, the mouse model (Apoe−/− mice in our study vs. C57BL/6 mice in the literature), and the composition of the HF diet (37% fat (lard) in our study vs. 60% (palm oil) in the literature). The Apoe−/− mice were characterized by dyslipidemia, which can easily result in hyperglycemia and excess diet intake [62].
The LF diet resulted in lower total and LDL cholesterol in plasma and lower atherosclerotic plaque amount compared with the HF diet (Figure 1), which is in line with Matziouridou et al. [63]. We also observed that the Wbean and Bfiber diets showed a tendency to lower atherosclerotic plaque amount compared with the HF diet. High blood cholesterol is a major risk factor for cardiovascular disease, and a reduced blood level of total cholesterol decreases the risk [64]. However, the bean diets did not affect plasma cholesterol levels (Figure 1). Thus, other factors might have contributed to the plaque-decreasing trend. One suggestion is that the bean diets reduced systematic inflammation, as a cross-sectional human study showed an inverse association between legume consumption and systematic inflammation [65]. It would be interesting to study the plasma levels of inflammatory markers, such as TNFα, and the colonic mRNA expression levels of inflammatory cytokines, such as IL-6 [65,66]. However, it is a limitation of our study that inflammatory markers were not analyzed, but could be a continuation for another study. The SCFAs produced by gut microbiota have also been proven to lower systematic inflammation in previous studies [49]. Interestingly, the bean diets enhanced the formation of cecal SCFAs (Figure 2), and the metabolic parameters regarding SCFAs were positively correlated with the mice in bean groups in PCA (Figure S4 in the Supplementary Material). Previous studies have suggested that the gut microbiota can be a factor in the progression of atherosclerosis [67]. In the present study, we identified two bacterial genera, Streptococcus and Ruminococcaceae, that were correlated with atherosclerotic plaque amount, which is in line with a previous suggestion that Streptococcus species can accelerate the increase in atherosclerotic plaques in Apoe−/− mice [68].
In summary, both the Wbean and Bfiber diets resulted in a tendency for lower atherosclerotic plaque amount, but did not positively affect body weight and plasma lipid profile compared with the HF diet. The Wbean diet led to a higher alpha diversity of gut microbiota compared with the HF control. Both bean diets resulted in higher relative abundance of Actinobacteria and Bacteroidetes, and lower F/B ratio. At the genus level, both bean diets showed similar effects on the stimulation of the growth of bacterial genera, such as unclassified S24-7, Prevotella, Bifidobacterium, and unclassified Clostridiales, and led to lower relative abundance of Lactobacillus. The Bfiber fraction also resulted in lower abundance of Oscillospira. A higher formation of all cecal SCFAs, a higher proportion of cecal propionic acid, and a lower proportion of cecal acetic acid were observed in mice on both bean diets. The bean diets also resulted in higher plasma TMAO concentrations compared with the HF diet, while the Bfiber diet led to lower plasma creatinine concentrations and the Wbean diet showed a lowering tendency. Brown bean is a traditional and important type of pulse consumed in Sweden. The present study reveals the in vivo effects of both the whole bean and bean-derived fiber fraction on the plasma lipids, atherosclerotic plaque amount, gut microbiota, and cecal SCFAs. Bean-derived dietary fiber is often the main component of bean byproducts. As the fiber fraction contributes considerably to the nutritional benefits of the whole bean, the value and utility of fiber-rich bean byproducts should not be neglected.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu14050937/s1, Table S1: Composition of the experimental diets; Table S2: Nutritional content and main flavonoids in the cooked whole brown bean (Wbean) and the isolated dietary fiber fraction (Bfiber); Figure S1: Monomeric composition (%) of total dietary fiber polysaccharides in cooked brown bean containing 27 g/100 g fiber on a dry weight basis; Figure S2: (A) Body weight gain, (B) cumulative diet consumption, (C) ratios of liver to body weight, (D) ratio of cecum to body weight, and (E) ratio of fat pads to body weight in mice fed a low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks; Figure S3: Cecal proportions (%) of (A) acetic acid, (B) propionic acid, (C) butyric acid, and (D) minor acids in Apoe−/− mice fed a control diet (low fat (LF) or high fat (HF)) or a bean diet (whole brown bean (Wbean), bean fiber (Bfiber)) in an HF setting for 10.5 weeks; Figure S4: Principal component analysis (PCA) biplot based on (A) organ and body weight and biomarkers and (B) bacteria obtained from mice fed a low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks.

Author Contributions

Conceptualization, J.L., M.E.H., C.M.W., M.N. and F.H.; methodology, J.L., M.E.H., C.M.W., M.N. and F.H.; software, S.B.; validation, J.L.; formal analysis, J.L.; investigation, J.L.; resources, C.M.W., M.N. and F.H.; data curation, S.B.; writing—original draft preparation, J.L.; writing—review and editing, M.E.H., C.M.W., M.B., S.B., M.N. and F.H.; supervision, M.E.H., C.M.W., M.B., M.N. and F.H.; funding acquisition, F.H. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by the Direktör Albert Påhlsson Foundation. The analysis of TMAO and related metabolites was funded by the Crafoordska Foundation (grant number: 20180874).

Institutional Review Board Statement

The animal study protocol was approved by the Malmö–Lund Ethics Committee on Animal Experiments (ethical approval number: 9874-20).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the article, Supplementary Material, or upon request to the authors.

Acknowledgments

A scholarship from the China Scholarship Council (CSC) for J.L. is gratefully acknowledged.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Sajjadi, F.; Gharipour, M.; Mohammadifard, N.; Nouri, F.; Maghroun, M.; Alikhasi, H. Relationship between legumes consumption and metabolic syndrome: Findings of the Isfahan Healthy Heart Program. ARYA Atheroscler. 2014, 10, 18–24. [Google Scholar]
  2. Bazzano, L.A.; He, J.; Ogden, L.G.; Loria, C.; Vupputuri, S.; Myers, L.; Whelton, P.K. Legume consumption and risk of coronary heart disease in US men and women. Arch. Intern. Med. 2001, 161, 2573–2578. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Bazzano, L.A.; Thompson, A.M.; Tees, M.T.; Nguyen, C.H.; Winham, D.M. Non-soy legume consumption lowers cholesterol levels: A meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 94–103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Monk, J.M.; Lepp, D.; Wu, W.; Pauls, K.P.; Robinson, L.E.; Power, K.A. Navy and black bean supplementation primes the colonic mucosal microenvironment to improve gut health. J. Nutr. Biochem. 2017, 49, 89–100. [Google Scholar] [CrossRef] [PubMed]
  5. Liu, J.; Hefni, M.E.; Witthoft, C.M. Characterization of flavonoid compounds in common Swedish berry species. Foods 2020, 9, 358. [Google Scholar] [CrossRef] [Green Version]
  6. Hernández-Salazar, M.; Osorio-Diaz, P.; Loarca-Piña, G.; Reynoso-Camacho, R.; Tovar, J.; Bello-Pérez, L.A. In vitro fermentability and antioxidant capacity of the indigestible fraction of cooked black beans (Phaseolus vulgaris L.), lentils (Lens culinaris L.) and chickpeas (Cicer arietinum L.). J. Sci. Food Agric. 2010, 90, 1417–1422. [Google Scholar] [CrossRef]
  7. Gómez de Cedrón, M.; Ramírez de Molina, A. Precision nutrition to target lipid metabolism alterations in cancer. In Precision Medicine for Investigators, Practitioners and Providers; Faintuch, J., Faintuch, S., Eds.; Academic Press: London, UK, 2020; pp. 291–299. [Google Scholar]
  8. Festi, D.; Schiumerini, R.; Eusebi, L.H.; Marasco, G.; Taddia, M.; Colecchia, A. Gut microbiota and metabolic syndrome. World J. Gastroenterol. 2014, 20, 16079–16094. [Google Scholar] [CrossRef]
  9. Ley, R.E.; Backhed, F.; Turnbaugh, P.; Lozupone, C.A.; Knight, R.D.; Gordon, J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 2005, 102, 11070–11075. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Human gut microbes associated with obesity. Nature 2006, 444, 1022–1023. [Google Scholar] [CrossRef] [PubMed]
  11. Araújo, J.R.; Tomas, J.; Brenner, C.; Sansonetti, P.J. Impact of high-fat diet on the intestinal microbiota and small intestinal physiology before and after the onset of obesity. Biochimie 2017, 141, 97–106. [Google Scholar] [CrossRef]
  12. Singh, R.K.; Chang, H.-W.; Yan, D.; Lee, K.M.; Ucmak, D.; Wong, K.; Abrouk, M.; Farahnik, B.; Nakamura, M.; Zhu, T.H.; et al. Influence of diet on the gut microbiome and implications for human health. J. Transl. Med. 2017, 15, 73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Teixeira-Guedes, C.; Sánchez-Moya, T.; Pereira-Wilson, C.; Ros-Berruezo, G.; López-Nicolás, R. In vitro modulation of gut microbiota and metabolism by cooked cowpea and black bean. Foods 2020, 9, 861. [Google Scholar] [CrossRef] [PubMed]
  14. Hou, D.; Zhao, Q.; Yousaf, L.; Khan, J.; Xue, Y.; Shen, Q. Consumption of mung bean (Vigna radiata L.) attenuates obesity, ameliorates lipid metabolic disorders and modifies the gut microbiota composition in mice fed a high-fat diet. J. Funct. Foods 2020, 64, 103687. [Google Scholar] [CrossRef]
  15. Tan, J.; McKenzie, C.; Potamitis, M.; Thorburn, A.N.; Mackay, C.R.; Macia, L. The role of short-chain fatty acids in health and disease. Adv. Immunol. 2014, 121, 91–119. [Google Scholar] [PubMed]
  16. Fåk, F.; Jakobsdottir, G.; Kulcinskaja, E.; Marungruang, N.; Matziouridou, C.; Nilsson, U.; Stålbrand, H.; Nyman, M. The physico-chemical properties of dietary fibre determine metabolic responses, short-chain fatty acid profiles and gut microbiota composition in rats fed low- and high-fat fiets. PLoS ONE 2015, 10, e0127252. [Google Scholar] [CrossRef] [Green Version]
  17. Vital, M.; Howe, A.C.; Tiedje, J.M. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio 2014, 5, e00889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Yang, S.; Li, X.; Yang, F.; Zhao, R.; Pan, X.; Liang, J.; Tian, L.; Li, X.; Liu, L.; Xing, Y.; et al. Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: Inflammation mechanism, clinical prognostic, and potential as a therapeutic target. Front. Pharmacol. 2019, 10, 1360. [Google Scholar] [CrossRef] [PubMed]
  19. Simó, C.; García-Cañas, V. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development. Food Funct. 2020, 11, 6745–6776. [Google Scholar] [CrossRef]
  20. Chhibber-Goel, J.; Singhal, V.; Parakh, N.; Bhargava, B.; Sharma, A. The metabolite trimethylamine-N-oxide is an emergent biomarker of human health. Curr. Med. Chem. 2017, 24, 3942–3953. [Google Scholar] [CrossRef]
  21. Blachier, F.; Nilsson, A.; Johansson, E.; Ekström, L.; Björck, I. Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: A randomized cross-over study. PLoS ONE 2013, 8, e59985. [Google Scholar]
  22. Protease (Subtilisin A from Bacillus licheniformis). Available online: https://www.megazyme.com/protease-subtilisin-a-bacillus-licheniformis (accessed on 1 October 2021).
  23. Amyloglucosidase (Aspergillus niger). Available online: https://www.megazyme.com/amyloglucosidase-aspergillus-niger (accessed on 1 October 2021).
  24. Theander, O.; Aman, P.; Westerlund, E.; Andersson, R.; Pettersson, D. Total dietary fiber determined as neutral sugar residues, uronic acid residues, and Klason lignin (the Uppsala method): Collaborative study. J. AOAC Int. 1995, 78, 1030–1044. [Google Scholar] [CrossRef]
  25. Hefni, M.E.; Bergström, M.; Lennqvist, T.; Fagerström, C.; Witthöft, C.M. Simultaneous quantification of trimethylamine N-oxide, trimethylamine, choline, betaine, creatinine, and propionyl-, acetyl-, and l-carnitine in clinical and food samples using HILIC-LC-MS. Anal. Bioanal. Chem. 2021, 413, 5349–5360. [Google Scholar] [CrossRef]
  26. Zhao, G.; Nyman, M.; Åke Jönsson, J. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomed. Chromatogr. 2006, 20, 674–682. [Google Scholar] [CrossRef]
  27. Klindworth, A.; Pruesse, E.; Schweer, T.; Peplies, J.; Quast, C.; Horn, M.; Glockner, F.O. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013, 41, e1. [Google Scholar] [CrossRef]
  28. Fabbri, A.D.T.; Schacht, R.W.; Crosby, G.A. Evaluation of resistant starch content of cooked black beans, pinto beans, and chickpeas. NFS J. 2016, 3, 8–12. [Google Scholar] [CrossRef] [Green Version]
  29. Henningsson, Å.M.; Margareta, E.; Nyman, G.L.; Björck, I.M.E. Content of short-chain fatty acids in the hindgut of rats fed processed bean (Phaseolus vulgaris) flours varying in distribution and content of indigestible carbohydrates. Br. J. Nutr. 2007, 86, 379–389. [Google Scholar] [CrossRef] [Green Version]
  30. Kriss, M.; Hazleton, K.Z.; Nusbacher, N.M.; Martin, C.G.; Lozupone, C.A. Low diversity gut microbiota dysbiosis: Drivers, functional implications and recovery. Curr. Opin. Microbiol. 2018, 44, 34–40. [Google Scholar] [CrossRef]
  31. Nabout, J.C.; Walters, K.E.; Martiny, J.B.H. Alpha-, beta-, and gamma-diversity of bacteria varies across habitats. PLoS ONE 2020, 15, e0233872. [Google Scholar]
  32. Kilua, A.; Chihiro, H.; Han, K.-h.; Homma, K.; Fukuma, N.; Kamitani, T.; Suzuki, T.; Fukushima, M. Whole kidney bean (Phaseolus vulgaris) and bean hull reduce the total serum cholesterol, modulate the gut microbiota and affect the caecal fermentation in rats. Bioact. Carbohydr. Diet. Fibre 2020, 24, 100232. [Google Scholar] [CrossRef]
  33. Neil, E.S.; McGinley, J.N.; Fitzgerald, V.K.; Lauck, C.A.; Tabke, J.A.; Streeter-McDonald, M.R.; Yao, L.; Broeckling, C.D.; Weir, T.L.; Foster, M.T.; et al. White kidney bean (Phaseolus Vulgaris L.) consumption reduces fat accumulation in a polygenic mouse model of obesity. Nutrients 2019, 11, 2780. [Google Scholar] [CrossRef] [Green Version]
  34. Zhao, S.; Liu, W.; Wang, J.; Shi, J.; Sun, Y.; Wang, W.; Ning, G.; Liu, R.; Hong, J. Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice. J. Mol. Endocrinol. 2017, 58, 1–14. [Google Scholar] [CrossRef] [PubMed]
  35. Li, J.; Lin, S.; Vanhoutte, P.M.; Woo, C.W.; Xu, A. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe−/− mice. Circulation 2016, 133, 2434–2446. [Google Scholar] [CrossRef] [Green Version]
  36. Bassaganya-Riera, J.; Jakobsdottir, G.; Xu, J.; Molin, G.; Ahrné, S.; Nyman, M. High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects. PLoS ONE 2013, 8, e80476. [Google Scholar]
  37. Slavin, J. Fiber and prebiotics: Mechanisms and health benefits. Nutrients 2013, 5, 1417–1435. [Google Scholar] [CrossRef] [Green Version]
  38. Sun, J.; Qiao, Y.; Qi, C.; Jiang, W.; Xiao, H.; Shi, Y.; Le, G.-w. High-fat-diet–induced obesity is associated with decreased antiinflammatory Lactobacillus reuteri sensitive to oxidative stress in mouse Peyer’s patches. Nutrition 2016, 32, 265–272. [Google Scholar] [CrossRef] [PubMed]
  39. Million, M.; Maraninchi, M.; Henry, M.; Armougom, F.; Richet, H.; Carrieri, P.; Valero, R.; Raccah, D.; Vialettes, B.; Raoult, D. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes. 2011, 36, 817–825. [Google Scholar] [CrossRef] [Green Version]
  40. Li, B.W.; Zhao, Z. Determination of starches and dietary fiber polysaccharides in cooked dried beans:  Comparison of different temperatures and dimethyl sulfoxide treatments. J. Agric. Food Chem. 1997, 45, 2598–2601. [Google Scholar] [CrossRef]
  41. Rose, D.J. Impact of whole grains on the gut microbiota: The next frontier for oats? Br. J. Nutr. 2014, 112, S44–S49. [Google Scholar] [CrossRef] [Green Version]
  42. Lin, L.; Zhang, J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017, 18, 2. [Google Scholar] [CrossRef] [Green Version]
  43. Corrêa-Oliveira, R.; Fachi, J.L.; Vieira, A.; Sato, F.T.; Vinolo, M.A.R. Regulation of immune cell function by short-chain fatty acids. Clin. Transl. Immunol. 2016, 5, e73. [Google Scholar] [CrossRef] [PubMed]
  44. McCleary, B.V. An integrated procedure for the measurement of total dietary fibre (including resistant starch), non-digestible oligosaccharides and available carbohydrates. Anal. Bioanal. Chem. 2007, 389, 291–308. [Google Scholar] [CrossRef]
  45. Noakes, M.; Clifton, P.M.; Nestel, P.J.; Le Leu, R.; McIntosh, G. Effect of high-amylose starch and oat bran on metabolic variables and bowel function in subjects with hypertriglyceridemia. Am. J. Clin. Nutr. 1996, 64, 944–951. [Google Scholar] [CrossRef] [Green Version]
  46. Van Munster, I.P.; Tangerman, A.; Nagengast, F.M. Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Dig. Dis. Sci. 1994, 39, 834–842. [Google Scholar] [CrossRef] [PubMed]
  47. Kapadia, S.A.; Raimundo, A.H.; Grimble, G.K.; Aimer, P.; Silk, D.B. Influence of three different fiber-supplemented enteral diets on bowel function and short-chain fatty acid production. JPEN J. Parenter. Enteral Nutr. 1995, 19, 63–68. [Google Scholar] [CrossRef]
  48. Nyangale, E.P.; Mottram, D.S.; Gibson, G.R. Gut microbial activity, implications for health and disease: The potential role of metabolite analysis. J. Proteome Res. 2012, 11, 5573–5585. [Google Scholar] [CrossRef] [PubMed]
  49. Jonsson, A.L.; Bäckhed, F. Role of gut microbiota in atherosclerosis. Nat. Rev. Cardiol. 2016, 14, 79–87. [Google Scholar] [CrossRef]
  50. Lindskog Jonsson, A.; Caesar, R.; Akrami, R.; Reinhardt, C.; Fåk Hållenius, F.; Boren, J.; Backhed, F. Impact of gut microbiota and diet on the development of atherosclerosis in Apoe(−/−) mice. Arterioscler. Thromb. Vasc. Biol. 2018, 38, 2318–2326. [Google Scholar] [CrossRef] [PubMed]
  51. Collins, H.L.; Drazul-Schrader, D.; Sulpizio, A.C.; Koster, P.D.; Williamson, Y.; Adelman, S.J.; Owen, K.; Sanli, T.; Bellamine, A. L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(−/−) transgenic mice expressing CETP. Atherosclerosis 2016, 244, 29–37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Koay, Y.C.; Chen, Y.-C.; Wali, J.A.; Luk, A.W.S.; Li, M.; Doma, H.; Reimark, R.; Zaldivia, M.T.K.; Habtom, H.T.; Franks, A.E.; et al. Plasma levels of trimethylamine-N-oxide can be increased with ‘healthy’ and ‘unhealthy’ diets and do not correlate with the extent of atherosclerosis but with plaque instability. Cardiovasc. Res. 2021, 117, 435–449. [Google Scholar] [CrossRef] [PubMed]
  53. Falls, J.G.; Blake, B.L.; Cao, Y.; Levi, P.E.; Hodgson, E. Gender differences in hepatic expression of flavin-containing monooxygenase isoforms (FMO1, FMO3, and FMO5) in mice. J. Biochem. Mol. Toxicol. 1995, 10, 171–177. [Google Scholar] [CrossRef] [PubMed]
  54. Lard. Available online: https://fdc.nal.usda.gov/fdc-app.html#/food-details/171401/nutrients (accessed on 1 October 2021).
  55. Zeisel, S.H.; Mar, M.-H.; Howe, J.C.; Holden, J.M. Concentrations of choline-containing compounds and betaine in common foods. J. Nutr. 2003, 133, 1302–1307. [Google Scholar] [CrossRef]
  56. Arduini, A.; Bonomini, M.; Savica, V.; Amato, A.; Zammit, V. Carnitine in metabolic disease: Potential for pharmacological intervention. Pharmacol. Ther. 2008, 120, 149–156. [Google Scholar] [CrossRef] [PubMed]
  57. Aronson, D.; Burger, A.J. The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J. Card. Fail. 2010, 16, 541–547. [Google Scholar] [CrossRef] [PubMed]
  58. Jameson, E.; Doxey, A.C.; Airs, R.; Purdy, K.J.; Murrell, J.C.; Chen, Y. Metagenomic data-mining reveals contrasting microbial populations responsible for trimethylamine formation in human gut and marine ecosystems. Microb. Genom. 2016, 2, e000080. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Meng, J.; Bai, Z.; Huang, W.; Liu, Y.; Wang, P.; Nie, S.; Huang, X. Polysaccharide from white kidney bean can improve hyperglycemia and hyperlipidemia in diabetic rats. Bioact. Carbohydr. Diet. Fibre 2020, 24, 100222. [Google Scholar] [CrossRef]
  60. Yeap, S.K.; Beh, B.K.; Ho, W.Y.; Mohd Yusof, H.; Mohamad, N.E.; Ali, N.M.; Jaganath, I.B.; Alitheen, N.B.; Koh, S.P.; Long, K. In vivo antioxidant and hypolipidemic effects of fermented mung bean on hypercholesterolemic mice. Evid. Based Complement. Altern. Med. 2015, 2015, 1–6. [Google Scholar] [CrossRef] [Green Version]
  61. Nguyen, A.T.; Althwab, S.; Qiu, H.; Zbasnik, R.; Urrea, C.; Carr, T.P.; Schlegel, V. Pinto beans (Phaseolus vulgaris L.) lower non-HDL cholesterol in hamsters fed a diet rich in saturated fat and act on genes involved in cholesterol homeostasis. J. Nutr. 2019, 149, 996–1003. [Google Scholar] [CrossRef] [PubMed]
  62. Li, J.; Wang, Q.; Chai, W.; Chen, M.-H.; Liu, Z.; Shi, W. Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility. Cardiovasc. Diabetol. 2011, 10, 117. [Google Scholar] [CrossRef] [Green Version]
  63. Matziouridou, C.; Marungruang, N.; Nguyen, T.D.; Nyman, M.; Fåk, F. Lingonberries reduce atherosclerosis in Apoe(−/−) mice in association with altered gut microbiota composition and improved lipid profile. Mol. Nutr. Food Res. 2016, 60, 1150–1160. [Google Scholar] [CrossRef] [PubMed]
  64. Grundy, S.M.; Stone, N.J.; Bailey, A.L.; Beam, C.; Birtcher, K.K.; Blumenthal, R.S.; Braun, L.T.; Ferranti, S.d.; Faiella-Tommasino, J.; Forman, D.E.; et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019, 139, e1082–e1143. [Google Scholar] [PubMed]
  65. Esmaillzadeh, A.; Azadbakht, L. Legume consumption is inversely associated with serum concentrations of adhesion molecules and inflammatory biomarkers among Iranian women. J. Nutr. 2012, 142, 334–339. [Google Scholar] [CrossRef] [Green Version]
  66. Zhang, C.; Monk, J.M.; Lu, J.T.; Zarepoor, L.; Wu, W.; Liu, R.; Pauls, K.P.; Wood, G.A.; Robinson, L.; Tsao, R.; et al. Cooked navy and black bean diets improve biomarkers of colon health and reduce inflammation during colitis. Br. J. Nutr. 2014, 111, 1549–1563. [Google Scholar] [CrossRef] [Green Version]
  67. Jones, M.L.; Martoni, C.J.; Ganopolsky, J.G.; Labbe, A.; Prakash, S. The human microbiome and bile acid metabolism: Dysbiosis, dysmetabolism, disease and intervention. Expert Opin. Biol. Ther. 2014, 14, 467–482. [Google Scholar] [CrossRef] [PubMed]
  68. Kesavalu, L.; Lucas, A.R.; Verma, R.K.; Liu, L.; Dai, E.; Sampson, E.; Progulske-Fox, A. Increased atherogenesis during Streptococcus mutans infection in ApoE-null mice. J. Dent. Res. 2012, 91, 255–260. [Google Scholar] [CrossRef] [Green Version]
Nutrients 14 00937 g001 550
Figure 1. Plasma levels of (A) total cholesterol, (B) total triglycerides, (C) high density lipoprotein (HDL) cholesterol, (D) low density lipoprotein (LDL) cholesterol, and (E) atherosclerotic plaque amount in the aortic root of mice fed different diets for 10.5 weeks. Values in low fat (LF) and high fat (HF) groups were compared using Student’s t-test (or Welch’s t-test for data with unequal SDs). Values in the high fat groups, i.e., HF, whole brown bean (Wbean), and bean fiber (Bfiber), were compared using one-way ANOVA (Welch’s ANOVA test for data with unequal SDs, or Kruskal–Wallis test for nonparametric data) followed by post hoc tests. Different lowercase letters within panels indicate significant differences (p < 0.05). ns: not significant. *** p < 0.001, **** p < 0.0001.
Figure 1. Plasma levels of (A) total cholesterol, (B) total triglycerides, (C) high density lipoprotein (HDL) cholesterol, (D) low density lipoprotein (LDL) cholesterol, and (E) atherosclerotic plaque amount in the aortic root of mice fed different diets for 10.5 weeks. Values in low fat (LF) and high fat (HF) groups were compared using Student’s t-test (or Welch’s t-test for data with unequal SDs). Values in the high fat groups, i.e., HF, whole brown bean (Wbean), and bean fiber (Bfiber), were compared using one-way ANOVA (Welch’s ANOVA test for data with unequal SDs, or Kruskal–Wallis test for nonparametric data) followed by post hoc tests. Different lowercase letters within panels indicate significant differences (p < 0.05). ns: not significant. *** p < 0.001, **** p < 0.0001.
Nutrients 14 00937 g001
Nutrients 14 00937 g002 550
Figure 2. Cecal pools (μmol) of (A) acetic acid, (B) propionic acid, (C) butyric acid, (D) minor acids and (E) the total short-chain fatty acids (SCFAs) in Apoe−/− mice fed a control diet (low fat (LF) or high fat (HF)) or a bean diet (whole brown bean (Wbean), bean fiber (Bfiber)) in a HF setting for 10.5 weeks. Minor acids include isobutyric acid, valeric acid, isovaleric acid, caproic acid, and heptanoic acid. Values in the LF and HF controls were compared using Student’s t-test. Values in the high fat groups, i.e., HF, Wbean, and Bfiber, were compared using one-way ANOVA followed by Tukey’s multiple comparison test. Different lowercase letters and symbol (*) within panels indicate significant differences (p < 0.05). ns: not significant.
Figure 2. Cecal pools (μmol) of (A) acetic acid, (B) propionic acid, (C) butyric acid, (D) minor acids and (E) the total short-chain fatty acids (SCFAs) in Apoe−/− mice fed a control diet (low fat (LF) or high fat (HF)) or a bean diet (whole brown bean (Wbean), bean fiber (Bfiber)) in a HF setting for 10.5 weeks. Minor acids include isobutyric acid, valeric acid, isovaleric acid, caproic acid, and heptanoic acid. Values in the LF and HF controls were compared using Student’s t-test. Values in the high fat groups, i.e., HF, Wbean, and Bfiber, were compared using one-way ANOVA followed by Tukey’s multiple comparison test. Different lowercase letters and symbol (*) within panels indicate significant differences (p < 0.05). ns: not significant.
Nutrients 14 00937 g002
Nutrients 14 00937 g003 550
Figure 3. Concentrations (μM) of plasma (A) trimethylamine N-oxide (TMAO), (B) choline, (C) creatinine, (D) betaine, (E) acetyl-carnitine, and (F) L-carnitine in Apoe−/− mice fed the low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks. Trimethylamine (TMA) concentrations were low (<3 μM) in all groups and no significant differences were observed. Values in the LF and HF controls were compared using Student’s t-test. Values in the high fat groups, i.e., HF, Wbean, and Bfiber, were compared using one-way ANOVA (Welch’s ANOVA test for data with unequal SDs, or Kruskal–Wallis test for nonparametric data) followed by post hoc tests. Different lowercase letters within panels indicate significant differences (p < 0.05). ns: not significant. * p < 0.05, ** p < 0.01.
Figure 3. Concentrations (μM) of plasma (A) trimethylamine N-oxide (TMAO), (B) choline, (C) creatinine, (D) betaine, (E) acetyl-carnitine, and (F) L-carnitine in Apoe−/− mice fed the low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks. Trimethylamine (TMA) concentrations were low (<3 μM) in all groups and no significant differences were observed. Values in the LF and HF controls were compared using Student’s t-test. Values in the high fat groups, i.e., HF, Wbean, and Bfiber, were compared using one-way ANOVA (Welch’s ANOVA test for data with unequal SDs, or Kruskal–Wallis test for nonparametric data) followed by post hoc tests. Different lowercase letters within panels indicate significant differences (p < 0.05). ns: not significant. * p < 0.05, ** p < 0.01.
Nutrients 14 00937 g003
Nutrients 14 00937 g004 550
Figure 4. (A) Chao1 rarefaction curves, (B) Shannon diversity index, and (C) unweighted and (D) weighted UniFrac principal coordinates analysis (PCoA) plots obtained from analyses of cecal samples from mice fed the low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks. Chao1 index values were compared using Student’s t-test for the two control groups and using Kruskal–Wallis test followed by Dunn’s multiple comparison test for the high fat groups, i.e., HF, Wbean, and Bfiber. Different lowercase letters and symbol (*) within panels indicate significant differences (p < 0.05). ns: not significant.
Figure 4. (A) Chao1 rarefaction curves, (B) Shannon diversity index, and (C) unweighted and (D) weighted UniFrac principal coordinates analysis (PCoA) plots obtained from analyses of cecal samples from mice fed the low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks. Chao1 index values were compared using Student’s t-test for the two control groups and using Kruskal–Wallis test followed by Dunn’s multiple comparison test for the high fat groups, i.e., HF, Wbean, and Bfiber. Different lowercase letters and symbol (*) within panels indicate significant differences (p < 0.05). ns: not significant.
Nutrients 14 00937 g004
Nutrients 14 00937 g005 550
Figure 5. (A) Relative abundance at phylum level of different gut microbial taxa and significant differences in (B) phyla and (C) Firmicutes/Bacteroidetes ratio detected for cecal samples from mice fed the low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks. Values in the LF and HF groups were compared using Welch’s t-test (or Mann–Whitney test for nonparametric data). Values in the high fat groups, i.e., HF, Wbean, and Bfiber, were compared using one-way ANOVA (Welch’s ANOVA test for data with unequal SDs, or Kruskal–Wallis test for nonparametric data) followed by post hoc tests. Different lowercase letters within panels indicate significant differences (p < 0.05). ns: not significant. *** p < 0.001.
Figure 5. (A) Relative abundance at phylum level of different gut microbial taxa and significant differences in (B) phyla and (C) Firmicutes/Bacteroidetes ratio detected for cecal samples from mice fed the low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks. Values in the LF and HF groups were compared using Welch’s t-test (or Mann–Whitney test for nonparametric data). Values in the high fat groups, i.e., HF, Wbean, and Bfiber, were compared using one-way ANOVA (Welch’s ANOVA test for data with unequal SDs, or Kruskal–Wallis test for nonparametric data) followed by post hoc tests. Different lowercase letters within panels indicate significant differences (p < 0.05). ns: not significant. *** p < 0.001.
Nutrients 14 00937 g005
Nutrients 14 00937 g006 550
Figure 6. (A) Microbial profile at genus level and (B) relative abundance of genera showing a significant difference or tendency in the cecum of mice fed a low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks. Values in the LF and HF groups were compared using Welch’s t-test (or Mann–Whitney test for nonparametric data). Values in the high fat groups, i.e., HF, Wbean, and Bfiber, were compared using one-way ANOVA (Welch’s ANOVA test for data with unequal SDs, or Kruskal–Wallis test for nonparametric data), followed by post hoc tests. Different lowercase letters above data for the HF setting groups indicate significant differences (p < 0.05). ns: not significant. * p < 0.05, ** p < 0.01.
Figure 6. (A) Microbial profile at genus level and (B) relative abundance of genera showing a significant difference or tendency in the cecum of mice fed a low fat (LF), high fat (HF), whole brown bean (Wbean), or bean fiber (Bfiber) diet for 10.5 weeks. Values in the LF and HF groups were compared using Welch’s t-test (or Mann–Whitney test for nonparametric data). Values in the high fat groups, i.e., HF, Wbean, and Bfiber, were compared using one-way ANOVA (Welch’s ANOVA test for data with unequal SDs, or Kruskal–Wallis test for nonparametric data), followed by post hoc tests. Different lowercase letters above data for the HF setting groups indicate significant differences (p < 0.05). ns: not significant. * p < 0.05, ** p < 0.01.
Nutrients 14 00937 g006
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Liu, J.; Hefni, M.E.; Witthöft, C.M.; Bergström, M.; Burleigh, S.; Nyman, M.; Hållenius, F. Effects of Whole Brown Bean and Its Isolated Fiber Fraction on Plasma Lipid Profile, Atherosclerosis, Gut Microbiota, and Microbiota-Dependent Metabolites in Apoe−/− Mice. Nutrients 2022, 14, 937. https://doi.org/10.3390/nu14050937

AMA Style

Liu J, Hefni ME, Witthöft CM, Bergström M, Burleigh S, Nyman M, Hållenius F. Effects of Whole Brown Bean and Its Isolated Fiber Fraction on Plasma Lipid Profile, Atherosclerosis, Gut Microbiota, and Microbiota-Dependent Metabolites in Apoe−/− Mice. Nutrients. 2022; 14(5):937. https://doi.org/10.3390/nu14050937

Chicago/Turabian Style

Liu, Jiyun, Mohammed E. Hefni, Cornelia M. Witthöft, Maria Bergström, Stephen Burleigh, Margareta Nyman, and Frida Hållenius. 2022. "Effects of Whole Brown Bean and Its Isolated Fiber Fraction on Plasma Lipid Profile, Atherosclerosis, Gut Microbiota, and Microbiota-Dependent Metabolites in Apoe−/− Mice" Nutrients 14, no. 5: 937. https://doi.org/10.3390/nu14050937

APA Style

Liu, J., Hefni, M. E., Witthöft, C. M., Bergström, M., Burleigh, S., Nyman, M., & Hållenius, F. (2022). Effects of Whole Brown Bean and Its Isolated Fiber Fraction on Plasma Lipid Profile, Atherosclerosis, Gut Microbiota, and Microbiota-Dependent Metabolites in Apoe−/− Mice. Nutrients, 14(5), 937. https://doi.org/10.3390/nu14050937

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop